Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation.
- DOI
- 10.3390/antibiotics12020226
- Published
- 2023 Jan 20
- Container
- Antibiotics (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/antibiotics12020226,
title = {Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation.},
author = {Herrera F and Torres D and Laborde A and Berruezo L and Jordán R and Rossi IR and Valledor A and Costantini P and Dictar M and Nenna A and Pereyra ML and Lambert S and Benso J and Poletta F and Gonzalez Ibañez ML and Baldoni N and Eusebio MJ and Lovano F and Barcán L and Luck M and Racioppi A and Tula L and Pasterán F and Corso A and Rapoport M and Nicola F and García Damiano MC and Carbone R and Monge R and Reynaldi M and Greco G and Bronzi M and Valle S and Chaves ML and Vilches V and Blanco M and Carena AÁ and Argentine Group for the Study of Bacteremia in Cancer and Stem Cell Transplant (ROCAS) Study},
year = {2023},
journal = {Antibiotics (Basel, Switzerland)},
doi = {10.3390/antibiotics12020226},
url = {https://doi.org/10.3390/antibiotics12020226}
}RIS
TY - JOUR TI - Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation. AU - Herrera F AU - Torres D AU - Laborde A AU - Berruezo L AU - Jordán R AU - Rossi IR AU - Valledor A AU - Costantini P AU - Dictar M AU - Nenna A AU - Pereyra ML AU - Lambert S AU - Benso J AU - Poletta F AU - Gonzalez Ibañez ML AU - Baldoni N AU - Eusebio MJ AU - Lovano F AU - Barcán L AU - Luck M AU - Racioppi A AU - Tula L AU - Pasterán F AU - Corso A AU - Rapoport M AU - Nicola F AU - García Damiano MC AU - Carbone R AU - Monge R AU - Reynaldi M AU - Greco G AU - Bronzi M AU - Valle S AU - Chaves ML AU - Vilches V AU - Blanco M AU - Carena AÁ AU - Argentine Group for the Study of Bacteremia in Cancer and Stem Cell Transplant (ROCAS) Study PY - 2023 JO - Antibiotics (Basel, Switzerland) DO - 10.3390/antibiotics12020226 UR - https://doi.org/10.3390/antibiotics12020226 ER -
APA
F, H., D, T., A, L., L, B., R, J., IR, R., A, V., P, C., M, D., A, N., ML, P., S, L., J, B., F, P., ML, G. I., N, B., MJ, E., F, L., L, B., M, L., A, R., L, T., F, P., A, C., M, R., F, N., MC, G. D., R, C., R, M., M, R., G, G., M, B., S, V., ML, C., V, V., M, B., AÁ, C., & Study, A. G. F. T. S. O. B. I. C. A. S. C. T. (. (2023). Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation.. Antibiotics (Basel, Switzerland). https://doi.org/10.3390/antibiotics12020226
Source records
- pubmed · retrieved 2026-09-26T06:30:19.090Z